Fanouriakis, A. Et Al. 2018. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.48, no.3 , 467-474.

Fanouriakis, A., Adamichou, C., Koutsoviti, S., Panopoulos, S., Staveri, C., Klagou, A., ... Tsalapaki, C.(2018). Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study. SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.48, no.3, 467-474.

Fanouriakis, Antonis Et Al. "Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study," SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.48, no.3, 467-474, 2018

Fanouriakis, Antonis Et Al. "Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study." SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.48, no.3, pp.467-474, 2018

Fanouriakis, A. Et Al. (2018) . "Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study." SEMINARS IN ARTHRITIS AND RHEUMATISM , vol.48, no.3, pp.467-474.

@article{article, author={Antonis Fanouriakis Et Al. }, title={Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study}, journal={SEMINARS IN ARTHRITIS AND RHEUMATISM}, year=2018, pages={467-474} }